alexa Association of aldosterone synthase (CYP11B2) -344 T C polymorphism with diabetic nephropathy: A meta-analysis.
Genetics & Molecular Biology

Genetics & Molecular Biology

Journal of Molecular Biomarkers & Diagnosis

Author(s): Xu H, Wang X, Liu M, Shao X, He X

Abstract Share this page

Abstract INTRODUCTION: Studies on the relation between aldosterone synthase -344 T/C polymorphism and diabetic nephropathy showed controversial conclusions. This meta-analysis aimed to systematically summarize the association between aldosterone synthase (CYP11B2) gene polymorphism and diabetic nephropathy risk. METHODS: Embase, PubMed, ScienceDirect, Web of Science, Wanfang Data, VIP Database, China Knowledge Resource Integrated Database and SinoMed have been searched. A total of five studies including 825 cases and 910 controls were included. RESULTS: In overall analysis, significant increased risk was found in recessive comparison (OR = 1.27, 95\% CI 1.05-1.55), homozygote comparison (OR = 1.39, 95\% CI 1.04-1.88) and allele comparison (OR = 1.20, 95\% CI = 1.05-1.39). No significant association was detected in dominant comparison (OR = 1.27, 95\% CI 0.97-1.66) and heterozygote comparison (OR = 1.17, 95\% CI 0.88-1.56). In subgroup analysis, significant increased risk existed in Asian population in allele comparison (OR = 1.45, 95\% CI = 1.17-1.79), dominant comparison (OR = 1.78, 95\% CI 1.11-2.87), homozygote comparison (OR = 2.11, 95\% CI 1.29-3.47), recessive comparison (OR = 1.54, 95\% CI 1.17-2.03), except for heterozygote comparison (OR = 1.44, 95\% CI 0.87-2.38). CONCLUSIONS: Our meta-analysis indicates that aldosterone synthase (CYP11B2) gene polymorphism may contribute to diabetic nephropathy development, especially in Asian group, with the T allele acting as a risk factor. © The Author(s) 2016. This article was published in J Renin Angiotensin Aldosterone Syst and referenced in Journal of Molecular Biomarkers & Diagnosis

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 9th International Conference and Expo on Molecular & Cancer Biomarkers
    August 23-24, 2017 Birmingham, UK
  • 2nd International Conference on Medical Imaging and Diagnosis
    London, UK
  • 22nd International Conference on Cancer Drugs and Therapeutics
    Paris, France
  • International Conference on Oncology Nursing and Cancer Care
    Singapore City, Singapore
  • World Summit on Cell Signalling and Cancer Therapy
    Toronto, Canada
  • International Conference on Radiology and Imaging
    New York, USA

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords